未登录Cadonilimab induction and consolidation for unresectable stage III non-small cell lung cancer patients receiving concurrent chemoradiation: safety run-in results of a prospective, phase II trial卡多尼利单抗诱导和巩固治疗不可切除的III期非小细胞肺癌患者接受同步放化疗：一项前瞻性II期试验的安全启动结果
Ni, Jianjiao; Zheng, Zilu; Yang, Xi; Chu, Xiao; Zhou, Yue; Pang, Yechun; Chen, Hongru; Yu, Silai; Liang, Fei; Zhu, Zhengfei; Chu, Li .png)
分享.png)
收藏Radiation-induced extracellular vesicles from cancer-associated fibroblasts drive oesophageal squamous cell carcinoma metastasis via the miR-193a-3p/PTEN/Akt pathway辐射诱导的肿瘤相关成纤维细胞来源的细胞外囊泡通过miR-193a-3p/PTEN/Akt通路驱动食管鳞状细胞癌转移Pang, Yechun; Guo, Tiantian; Zhou, Yue; Jiang, Shanshan; Li, Yida; Ni, Jianjiao; Chu, Xiao; Chu, Li; Chen, Fangyu; Yang, Xi; Zhu, Zhengfei 分享 收藏 分享 收藏 Early local therapy in combination with PD-1/PD-L1 inhibitors in oligometastatic non-small cell lung cancer: results from a prospective multicenter observational study寡转移性非小细胞肺癌的早期局部治疗联合PD-1/PD-L1抑制剂：一项前瞻性多中心观察性研究的结果Gao, Jie; Lan, Aihua; Yang, Xi; Chu, Li; Chu, Xiao; Zhou, Yue; Chen, Hongru; Yu, Silai; Pang, Yechun; Hu, Jie; Chu, Qian; Ni, Jianjiao; Zhu, Zhengfei 分享 收藏 Identification of a novel subtype of SPP1+macrophages expressing SIRPα: implications for tumor immune evasion and treatment response predictionChen, Kun; Li, Yida; Ni, Jianjiao; Yang, Xi; Zhou, Yue; Pang, Yechun; Ye, Ruiting; Chen, Hongru; Yu, Silai; Wang, Peng; Zhu, Zhengfei 分享 收藏 Safety and efficacy fi cacy of consolidative stereotactic radiotherapy for oligo-residual EGFR-mutant non-small cell lung cancer after fi rst-line third-generation EGFR-tyrosine kinase inhibitors: a single-arm, phase 2 trial第一代EGFR-酪氨酸激酶抑制剂治疗后少残留EGFR突变非小细胞肺癌的巩固立体定向放射治疗的安全性和有效性: 一项单臂2期试验Zhou, Yue; Peng, Lin; Liang, Fei; Chu, Li; Chu, Xiao; Yang, Xi; Zhang, Junhua; Guo, Tiantian; Jiang, Shanshan; Pang, Yechun; Wang, Zezhou; Zhang, Li; Ni, Jianjiao; Zhu, Zhengfei 分享 收藏 Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trialNi, Jianjiao; Wang, Xiaofei; Wu, Lin; Ai, Xinghao; Chu, Qian; Han, Chengbo; Dong, Xiaorong; Zhou, Yue; Pang, Yechun; Zhu, Zhengfei 分享 收藏 分享 收藏 分享 收藏 MiR-323a regulates ErbB3/EGFR and blocks gefitinib resistance acquisition in colorectal cancerZhang, Yuanzhou; Liang, Shunshun; Xiao, Bowen; Hu, Jingying; Pang, Yechun; Liu, Yuling; Yang, Juan; Ao, Junpin; Wei, Lin; Luo, Xiaoying 分享 收藏 MiR-103a promotes tumour growth and influences glucose metabolism in hepatocellular carcinomaLiu, Yuling; Zhang, Yuanzhou; Xiao, Bowen; Tang, Ning; Hu, Jingying; Liang, Shunshun; Pang, Yechun; Xu, Huili; Ao, Junping; Yang, Juan; Liang, Xiaofei; Wei, Lin; Wang, Yunfeng; Luo, Xiaoying 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
